Literature DB >> 2248506

Normal small bowel biopsy followed by coeliac disease.

M Mäki1, K Holm, S Koskimies, O Hällström, J K Visakorpi.   

Abstract

We report four patients (two children, one adolescent, and one adult) having normal small bowel mucosa shown on a biopsy specimen taken before the initial diagnosis of coeliac disease was made. The first biopsy was undertaken in two cases because of suspected malabsorption, in the third because of suspected dermatitis herpetiformis, and in the fourth as part of a coeliac disease family study. After a further 2.6 to 9 years on a diet containing gluten, small bowel villous atrophy with crypt hyperplasia compatible with coeliac disease was found on a second biopsy specimen. The HLA type of the patients was that typical for coeliac disease; all were DR3 positive. Within the families three other patients with coeliac disease have been diagnosed, two earlier and one at the time the first biopsy was undertaken. Four other HLA-DR3 positive haploidentical first degree relatives were found and had biopsies. All four had normal small bowel villous architecture, one had an increased intraepithelial cell count, and another was positive for reticulin and endomysium antibodies. Coeliac disease may exist latent in patients having normal mucosa when eating a normal diet containing gluten.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2248506      PMCID: PMC1792364          DOI: 10.1136/adc.65.10.1137

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  19 in total

1.  Effect of gluten supplementation in healthy siblings of children with celiac disease.

Authors:  I Polanco; M L Mearin; J Larrauri; I Biemond; A Wipkink-Bakker; A S Peña
Journal:  Gastroenterology       Date:  1987-03       Impact factor: 22.682

2.  A simple micro cytotoxicity test.

Authors:  D B Amos; H Bashir; W Boyle; M MacQueen; A Tiilikainen
Journal:  Transplantation       Date:  1969-03       Impact factor: 4.939

3.  Childhood coeliac disease is disappearing.

Authors:  J F Dossetor; A A Gibson; A S McNeish
Journal:  Lancet       Date:  1981-02-07       Impact factor: 79.321

4.  Changes in clinical features of coeliac disease in adults in Edinburgh and the Lothians 1960-79.

Authors:  R F Logan; G Tucker; E A Rifkind; R C Heading; A Ferguson
Journal:  Br Med J (Clin Res Ed)       Date:  1983-01-08

5.  Reintroduction of gluten in adults and children with treated coeliac disease.

Authors:  P J Kumar; D P O'Donoghue; K Stenson; A M Dawson
Journal:  Gut       Date:  1979-09       Impact factor: 23.059

6.  Evaluation of a serum IgA-class reticulin antibody test for the detection of childhood celiac disease.

Authors:  M Mäki; O Hällström; T Vesikari; J K Visakorpi
Journal:  J Pediatr       Date:  1984-12       Impact factor: 4.406

7.  HLA antigens and atopy in children with coeliac disease.

Authors:  M Verkasalo; A Tiilikainen; P Kuitunen; E Savilahti; A Backman
Journal:  Gut       Date:  1983-04       Impact factor: 23.059

8.  IgA antigliadin antibodies: a marker of mucosal damage in childhood coeliac disease.

Authors:  E Savilahti; M Viander; M Perkkiö; E Vainio; K Kalimo; T Reunala
Journal:  Lancet       Date:  1983-02-12       Impact factor: 79.321

9.  Atypical coeliac disease found with serologic screening.

Authors:  P Collin; O Hällström; M Mäki; M Viander; O Keyriläinen
Journal:  Scand J Gastroenterol       Date:  1990-03       Impact factor: 2.423

10.  Late mucosal relapse in a boy with coeliac disease and cow's milk allergy.

Authors:  P Kuitunen; E Savilahti; M Verkasalo
Journal:  Acta Paediatr Scand       Date:  1986-03
View more
  37 in total

1.  Serological markers and HLA-DQ2 haplotype among first-degree relatives of celiac patients. Catalonian Coeliac Disease Study Group.

Authors:  C Farré; P Humbert; P Vilar; V Varea; X Aldeguer; J Carnicer; M Carballo; M A Gassull
Journal:  Dig Dis Sci       Date:  1999-11       Impact factor: 3.199

Review 2.  Do you still need a biopsy to diagnose celiac disease?

Authors:  S Guandalini; P Gupta
Journal:  Curr Gastroenterol Rep       Date:  2001-10

3.  Increase in gamma/delta T cell receptor bearing lymphocytes in normal small bowel mucosa in latent coeliac disease.

Authors:  M Mäki; K Holm; P Collin; E Savilahti
Journal:  Gut       Date:  1991-11       Impact factor: 23.059

4.  The changing face of celiac disease.

Authors:  R Lad; K Jacobson
Journal:  Paediatr Child Health       Date:  2001-11       Impact factor: 2.253

Review 5.  Recent Advances in Celiac Disease.

Authors:  Simon Murch
Journal:  Indian J Pediatr       Date:  2016-06-08       Impact factor: 1.967

6.  Phenotypical characterization of peripheral blood T cells in patients with coeliac disease: elevation of antigen-primed CD45RO+ T lymphocytes.

Authors:  T O Kerttula; O Hällström; M Mäki
Journal:  Immunology       Date:  1995-09       Impact factor: 7.397

7.  ACP Broadsheet No 149: September 1996. Serological diagnosis of gluten sensitive enteropathy.

Authors:  D J Unsworth
Journal:  J Clin Pathol       Date:  1996-09       Impact factor: 3.411

8.  Anti-alpha-gliadin antibodies (AGA) in the serum of coeliac children and controls recognize an identical collection of linear epitopes of alpha-gliadin.

Authors:  M ten Dam; Y Van De Wal; M L Mearin; Y Kooy; S Peña; J W Drijfhout; F Koning; M Van Tol
Journal:  Clin Exp Immunol       Date:  1998-11       Impact factor: 4.330

9.  Immunohistochemical changes in the jejunum in first degree relatives of patients with coeliac disease and the coeliac disease marker DQ genes. HLA class II antigen expression, interleukin-2 receptor positive cells and dividing crypt cells.

Authors:  K Holm; E Savilahti; S Koskimies; V Lipsanen; M Mäki
Journal:  Gut       Date:  1994-01       Impact factor: 23.059

10.  Serological responses to microbial antigens in celiac disease patients during a gluten-free diet.

Authors:  Sara Ashorn; Tuuli Välineva; Katri Kaukinen; Merja Ashorn; Jonathan Braun; Hanna Raukola; Immo Rantala; Pekka Collin; Markku Mäki; Tiina Luukkaala; Sari Iltanen
Journal:  J Clin Immunol       Date:  2008-11-06       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.